Sidley represented Walgreens Boots Alliance, Ropes & Gray advised Welsh, Carson, Anderson & Stowe, while Goodwin Procter and K&L Gates advised Shields on the deal. Walgreens...
You must be a Standard 1 Year member to access this content.
Goodwin Procter represented Wayfair, while Davis Polk advised the representatives of the initial purchasers in the offering. Wayfair Inc. completed its offering of $690 million aggregate principal...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Alnylam Pharmaceuticals, Inc. on the deal, while Davis Polk advised the representative of the initial purchasers. Alnylam Pharmaceuticals, Inc. announced its inaugural offering...
You must be a Standard 1 Year member to access this content.
VISCHER AG advised Versantis with Mark Fitzpatrick as CEO, Vincent Forster as CSO and Meriam Kabbaj as COO. Goodwin advised the sellers. Linklaters and Niederer Kraft...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised a syndicate of investors on the deal. Bird & Bird advised SparingVision. SparingVision, a genomic medicines company with a mission to translate pioneering...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Devialet on the deal. Devialet, a French High-end speaker manufacturer, announced its €50 million financing. For this operation, Devialet was able to count on...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised North Island Ventures on the deal. North Island Ventures announced the closing of its NIV Fund II with $125 million in commitments. With this...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Citizens Financial Group, Inc. on the deal. Citizens Financial Group, Inc. (NYSE: CFG) announced its definitive agreement to acquire College Raptor, Inc. Citizens is...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised ACELYRIN on the deal. ACELYRIN announced the completion of its $300 million Series C financing round which was led by Access Biotechnology with participation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Legend Capital on the deal. Legend Capital announced its leading investment in Nuwacell Biotechnologies’ Series A financing round. Legend Capital is a private equity...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Ducentis BioTherapeutics on the deal. Ducentis BioTherapeutics announced its acquisition by Arcutis Biotherapeutics for up to $400 million. Ducentis BioTherapeutics, a portfolio company of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TIME on the deal. TIME announced its acquisition of Brandcast, the leading no-code platform for creating and managing enterprise-grade websites. Through the acquisition, Brandcast’s...
You must be a Standard 1 Year member to access this content.
